Phase I Study of IPI-504 and Docetaxel in Patients With Advanced Solid Tumors
Clinical trial NCT00606814 · COMPLETED
Trial details
- NCT number
- NCT00606814
- Sponsor
- Infinity Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2007-12-01
- Primary completion
- 2011-05-01
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.